Your browser doesn't support javascript.
loading
Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models.
Ko, Dongjoon; Kim, Eunmi; Shin, Eun-Ae; Nam, Seo Hee; Yoon, Junghwa; Lee, Jin-Sook; Lee, Yunhee; Park, Sora; Ha, Kyungsoo; Choi, So-Young; Lee, Jung Weon; Kim, Semi.
Afiliación
  • Ko D; Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-gu, Daejon 34141, Korea.
  • Kim E; Department of Functional Genomics, Korea University of Science and Technology, Daejon 34113, Korea.
  • Shin EA; Department of Pharmacy Research Institute of Pharmaceutical Sciences College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-Gu, Seoul 08826, Korea.
  • Nam SH; Department of Pharmacy Research Institute of Pharmaceutical Sciences College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-Gu, Seoul 08826, Korea.
  • Yoon J; Department of Pharmacy Research Institute of Pharmaceutical Sciences College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-Gu, Seoul 08826, Korea.
  • Lee JS; Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-gu, Daejon 34141, Korea.
  • Lee Y; Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-gu, Daejon 34141, Korea.
  • Park S; Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-gu, Daejon 34141, Korea.
  • Ha K; Antibody Drug Team at New Drug Development Center, Osong Medical Innovation Foundation, Osong 28160, Korea.
  • Choi SY; Drug Efficacy Evaluation Team at New Drug Development Center, Osong Medical Innovation Foundation, Osong 28160, Korea.
  • Lee JW; Protein Drug Team at New Drug Development Center, Osong Medical Innovation Foundation, Osong 28160, Korea.
  • Kim S; Department of Pharmacy Research Institute of Pharmaceutical Sciences College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-Gu, Seoul 08826, Korea.
Mol Ther Oncolytics ; 24: 452-466, 2022 Mar 17.
Article en En | MEDLINE | ID: mdl-35211652
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos